Seguici
IT
IT

Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie

Archivio

✕
9 febbraio 2018
5127
HIV prevention drug Truvada to be publicly funded in New Zealand

HIV prevention drug Truvada to be publicly funded in New Zealand

Pharmac estimates up to 4,000 people with a high risk of contracting HIV will be eligible for a drug to prevent infection with the virus which the Government's drug buying agency will now fund. New Zealand will be one of the first countries in the world to publicly fund ...
9 febbraio 2018
4980
Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole is stepping down as amfAR chairman, the designer announced Wednesday night at the charity's annual gala in New York.
9 febbraio 2018
5181
Ukraine Expands Opioid Substitution Therapy to Reduce HIV

Ukraine Expands Opioid Substitution Therapy to Reduce HIV

The Ukrainian government is increasing the scope of the country’s state-funded opioid substitution therapy programme – a harm reduction tool which reduces the risk of overdose and disease transmission.
8 febbraio 2018
4921
Scientists report big improvements in HIV vaccine production

Scientists report big improvements in HIV vaccine production

Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested.
8 febbraio 2018
7460
FDA Approves Gilead’s Biktarvy for Treatment of HIV

FDA Approves Gilead’s Biktarvy for Treatment of HIV

Food and Drug Administration has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen for the treatment of HIV-1 infection.
7 febbraio 2018
4781
New data helps prioritise groups for HIV treatment

New data helps prioritise groups for HIV treatment

People aged 50 or over, individuals with low CD4 to CD8 ratios, and those with high viral loads are the groups that benefit the most from immediate antiretroviral treatment.
7 febbraio 2018
5411
New insight into how some viruses establish a chronic infection

New insight into how some viruses establish a chronic infection

The previously undiscovered molecular mechanism explains how certain viruses, including HIV and hepatitis C, can actively make immune cells less functional, allowing an infection to spread ahead of the body's immune response.
6 febbraio 2018
7827
Persian shallot could help fight TB antibiotic resistance

Persian shallot could help fight TB antibiotic resistance

A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a study has suggested.
6 febbraio 2018
8322
Mobile app for free condoms launched in the Philippines

Mobile app for free condoms launched in the Philippines

To tackle low condom use, activists have teamed up with restaurants and shops to set up dispensers with free condoms in the capital Manila which users can locate through an app.
5 febbraio 2018
5574
Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

According to the study authors, HIV-infected hospitalized children initiating antiretroviral therapy are part of “a group in which tuberculosis diagnosis is often missed, and in whom early tuberculosis treatment is lifesaving.”
Utilizziamo i cookie su questo sito per migliorare la tua esperienza.
Facendo clic su qualsiasi pulsante di questo sito Web, dai il tuo consenso per l'impostazione dei cookie.